pcDNA3.1+_TRE3G_luciferase
(Plasmid
#240266)
-
PurposeCircuit-responsive (TRE3G promoter) expression of firefly luciferase. Used for evaluation of tTA/rtTA-3G transgene activity.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 240266 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Vector typeMammalian Expression, Luciferase
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namefirefly luciferase
-
Alt nameLUC
-
SpeciesPhotinus pyralis
- Promoter TRE3G
Cloning Information
- Cloning method Other
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made bySteven Carr, Samuel Myers (Addgene #97421), and Jeff Holst.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The TRE3G sequence was PCR-amplified from Addgene #97421.
The luciferase gene was PCR-amplified from plasmid pBCKS(HIV-1SDmCMVeGFP-P2A-luc2pre-IIU) described in Tiffen et al., 2010 (https://doi.org/10.1186/1476-4598-9-299)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1+_TRE3G_luciferase was a gift from Gregory Neely (Addgene plasmid # 240266 ; http://n2t.net/addgene:240266 ; RRID:Addgene_240266) -
For your References section:
A chimeric viral platform for directed evolution in mammalian cells. Cole AJ, Denes CE, Moreno CL, Hunault L, Dobson T, Hesselson D, Neely GG. Nat Commun. 2025 May 7;16(1):4250. doi: 10.1038/s41467-025-59438-2. 10.1038/s41467-025-59438-2 PubMed 40335481